Related Experiment Video
Updated: Sep 30, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal
Julia B Cordero1, Mario Cozzolino, Yan Lu
1Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract:
1,25(OH)(2)D(3) antiproliferative properties are widely known. However, the molecular bases of these properties are only partially elucidated. Since 1,25(OH)(2)D(3) effectively arrests growth in many tumors and hyperplastic tissues whose growth is driven by co-expression of EGFR and its ligand TGF-alpha, it was hypothesized that 1,25(OH)(2)D(3) could affect the TGF-alpha/EGFR-autocrine growth loop. This study examined 1,25(OH)(2)D(3) regulation of EGFR-growth signals, using human epidermoid A431 cells, in which the overexpression of EGFR and TGF-alpha constitute the major autocrine mitogenic signal. 1,25(OH)(2)D(3) inhibited autocrine and EGF-induced A431 cell proliferation. Furthermore, 1,25(OH)(2)D(3) changed the cellular localization of both TGF-alpha and EGFR and inhibited ligand-dependent phosphorylation of EGFR and ERK1/2. In addition, 1,25(OH)(2)D(3) impaired autocrine and EGF-induced nuclear translocation of activated EGFR and, consequently, its binding to AT-rich DNA sequences and transcriptional activation of the cyclin D1 promoter. These results demonstrate that 1,25(OH)(2)D(3) alters EGFR membrane trafficking and down-regulates EGFR growth signaling.
Insights
1,25(OH)(2)D(3) (calcitriol) inhibits cancer cell growth by disrupting the TGF-alpha/EGFR signaling pathway. This vitamin D3 metabolite alters epidermal growth factor receptor (EGFR) localization and reduces downstream signaling, impacting cell proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- The antiproliferative effects of 1,25(OH)(2)D(3) (calcitriol) are established but not fully understood at the molecular level.
- Tumor and hyperplastic tissue growth driven by co-expressed epidermal growth factor receptor (EGFR) and transforming growth factor-alpha (TGF-alpha) are sensitive to 1,25(OH)(2)D(3).
Purpose of the Study:
- To investigate the hypothesis that 1,25(OH)(2)D(3) modulates the TGF-alpha/EGFR autocrine growth loop.
- To elucidate the molecular mechanisms by which 1,25(OH)(2)D(3) regulates EGFR-mediated growth signals.
Main Methods:
- Utilized human epidermoid A431 cells, characterized by EGFR and TGF-alpha overexpression driving autocrine signaling.
- Assessed the effects of 1,25(OH)(2)D(3) on A431 cell proliferation, EGFR and TGF-alpha cellular localization, EGFR and ERK1/2 phosphorylation, and EGFR nuclear translocation.
Main Results:
- 1,25(OH)(2)D(3) significantly inhibited both autocrine and epidermal growth factor (EGF)-induced A431 cell proliferation.
- Observed alterations in the cellular distribution of TGF-alpha and EGFR, alongside inhibition of ligand-dependent EGFR and ERK1/2 phosphorylation.
- Demonstrated impaired nuclear translocation of activated EGFR, reduced binding to AT-rich DNA sequences, and decreased cyclin D1 promoter transcriptional activity.
Conclusions:
- 1,25(OH)(2)D(3) effectively down-regulates EGFR growth signaling by altering EGFR membrane trafficking.
- The findings reveal a novel mechanism for the antiproliferative action of 1,25(OH)(2)D(3) involving the disruption of the EGFR signaling pathway.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

